| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $709.3M | -20.2% |
| Cost of Revenue | $549.7M | -18.3% |
| R&D Expense | $1.4M | +0.0% |
| SG&A Expense | $79.6M | -8.2% |
| Operating Income | -$15.5M | -127.2% |
| Pre-tax Income | -$52.4M | -336.0% |
| Income Tax | $600K | -80.0% |
| Net Income | -$53.0M | -376.0% |
| EPS (Basic) | -$3.27 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $91.6M | -18.6% |
| Accounts Receivable | $96.9M | -23.7% |
| Inventory | $31.0M | -7.5% |
| Current Assets | $233.0M | -19.7% |
| Total Assets | $456.3M | -15.5% |
| Current Liabilities | $140.1M | -14.6% |
| Long-term Debt | $285.1M | +0.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $54.2M | -53.1% |
| Capital Expenditures | $65.1M | +14.0% |
| Investing Cash Flow | -$51.1M | -28.7% |
| Financing Cash Flow | -$24.0M | -15.4% |
| Free Cash Flow | -$10.9M | -118.6% |
| -365.9% |
| EPS (Diluted) | -$3.27 | -368.0% |
| Stockholders' Equity |
| -$10.5M |
| -127.1% |